STOCK TITAN

EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Edwards Lifesciences Corporation (NYSE: EW) announced its participation in the Bernstein 38th Annual Strategic Decisions Conference on June 2, 2022. CEO Michael A. Mussallem will present at 1:30 p.m. ET. The presentation will be accessible via a live webcast on the company's investor relations website, ir.edwards.com, with an archived version available later the same day. Edwards Lifesciences focuses on patient-centric innovations for structural heart disease and critical care monitoring.

Positive
  • None.
Negative
  • None.

IRVINE, Calif., May 23, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the Bernstein 38th Annual Strategic Decisions Conference on Thursday, June 2, 2022. 

 Michael A. Mussallem, chairman and chief executive officer, is scheduled to speak to conference attendees at 1:30 p.m. ET.  A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com/.  An archived version of the webcast will be available later that day on the Edwards' investor relations website.

About Edwards Lifesciences
Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart disease and critical care monitoring.  We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.  For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.  All other trademarks are the property of their respective owners.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-bernstein-38th-annual-strategic-decisions-conference-301552650.html

SOURCE Edwards Lifesciences Corporation

FAQ

What is the date of Edwards Lifesciences' presentation at the Bernstein Conference?

Edwards Lifesciences is scheduled to present on June 2, 2022.

What time will Edwards Lifesciences present at the conference?

The presentation will take place at 1:30 p.m. ET.

Where can I watch the Edwards Lifesciences presentation?

The presentation will be available via a live webcast on the Edwards Lifesciences investor relations website.

Who will speak for Edwards Lifesciences at the conference?

CEO Michael A. Mussallem is scheduled to speak at the conference.

What is the focus of Edwards Lifesciences Corporation?

Edwards Lifesciences specializes in innovations for structural heart disease and critical care monitoring.

Edwards Lifesciences Corp

NYSE:EW

EW Rankings

EW Latest News

EW Stock Data

43.57B
584.29M
0.91%
85.91%
1.16%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
IRVINE